Cerebral amyloid angiopathy with severe secondary vascular pathology: a histopathological study

Jack van Horssen1, Danielle de Jong, Robert M W de Waal

  • 1Department of Pathology, University Medical Center, Nijmegen, The Netherlands.

Insights

Severe cerebral amyloid angiopathy (CAA) can cause vascular changes leading to cognitive decline, even without large hemorrhages. This study details these changes and their potential impact on brain function.

Area of Science:

  • Neuropathology
  • Vascular Biology
  • Cognitive Neuroscience

Background:

  • Cerebral amyloid angiopathy (CAA) involves amyloid deposition in brain vessels.
  • CAA is a common finding in neuropathological studies.
  • Secondary vascular changes can complicate severe CAA.

Purpose of the Study:

  • To describe neuropathological findings in severe CAA with secondary vascular changes.
  • To investigate the association between these changes and clinical outcomes (hemorrhage, ischemia).
  • To explore the potential contribution of severe CAA to cognitive decline.

Main Methods:

  • Macroscopic and microscopic neuropathological examination of 5 patients with severe CAA.
  • Detailed analysis of vascular changes including smooth muscle cell degeneration, hyalinization, and aneurysmal dilatation.
  • Correlation of neuropathological findings with clinical presentation of hemorrhages or ischemic necrosis.

Main Results:

  • Severe CAA was associated with significant secondary vascular pathologies in all 5 patients.
  • Three patients exhibited multiple small hemorrhages, while two showed ischemic necrosis.
  • No large lobar hemorrhages were observed in this cohort.
  • Vascular changes included smooth muscle cell degeneration, hyalinization, and aneurysmal dilatation.

Conclusions:

  • Severe CAA with secondary vascular pathology can mimic vascular dementia-like ischemic changes.
  • Distinguishing severe CAA from vascular dementia can be challenging due to overlapping features.
  • CAA-related vascular changes may contribute to cognitive decline, warranting further investigation.

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...